hims compounded glp-1 Readout Newsletter: Makary hearing, Hims, Nimbus, Ozempic Hims Just Launched an Ozempic

SELECT showed 20% MACE reduction with semaglutide in patients with established cardiovascular disease, and the secondary cardiovascular benefits (blood pressure, lipids, glucose) may help reduce occupational cardiovascular events

One way to circumvent the problem of lack of cost savings is to better target reimbursement by stratifying subgroups of obese patients into those expected to benefit the most versus those for whom the return isnt as good

Despite these divergent pathways, both sexes converged on the same endpoint: a desperate, compensatory upregulation of intracellular glutathione in immune cells that ultimately drains the hosts systemic energy

Spoken like a true hit piece